NCT00178932View on ClinicalTrials.gov

Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 1998

Primary Completion Date

May 16, 2024

Study Completion Date

May 16, 2024

Conditions
SchizophreniaSchizoaffective DisorderBipolar DisorderMajor Depression
Interventions
PROCEDURE

genetic analysis

genetic assay of blood sample drawn with patient's consent

PROCEDURE

genetic assay

genetic assay of blood sample drawn with patient's consent

Trial Locations (1)

37212

Psychiatric Hospital at Vanderbilt, Nashville

All Listed Sponsors
lead

Northwestern University

OTHER

NCT00178932 - Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors | Biotech Hunter | Biotech Hunter